OPTO-ACOUSTIC BREAST IMAGING

Similar documents
OPTO-ACOUSTIC BREAST IMAGING

A Pivotal Study of Opto-Acoustic Imaging to Diagnose Benign and Malignant Breast Masses: A New Evaluation Tool for Radiologists

Title: Opto-Acoustic Breast Imaging Imaging-Pathology Correlation of Opto-Acoustic

A Pivotal Study of Optoacoustic Imaging to Diagnose Benign and Malignant Breast Masses: A New Evaluation Tool for Radiologists 1

Clinical feasibility of co-registered opto-acoustic and ultrasonic imaging for differentiation of breast tumors

Real-time opto-acoustic imaging system for clinical assessment of breast lesions

Does elastography change the indication to biopsy? IBDC

EARLY DETECTION: MAMMOGRAPHY AND SONOGRAPHY

EARLY DETECTION: MAMMOGRAPHY AND SONOGRAPHY

Leonard M. Glassman MD

This copy is for personal use only. To order printed copies, contact

Current Status of Supplementary Screening With Breast Ultrasound

Pitfalls and Limitations of Breast MRI. Susan Orel Roth, MD Professor of Radiology University of Pennsylvania

MAESTRO TRIAL FINAL RESULTS. Gisela L.G. Menezes, MD, PhD

Innovations in Ultrasound & Breast Cancer Imaging

Mammographic imaging of nonpalpable breast lesions. Malai Muttarak, MD Department of Radiology Chiang Mai University Chiang Mai, Thailand

Electrical impedance scanning of the breast is considered investigational and is not covered.

Diagnostic Ultrasound. Sutiporn Khampunnip, M.D.

Ultrasonography. Methods. Brief Description. Indications. Device-related Prerequisites. Technical Requirements. Evaluation Criteria

GTC 2018, San Jose, USA

Evolution of diagnostic ultrasound systems Current achievements in breast ultrasound

Mammography limitations. Clinical performance of digital breast tomosynthesis compared to digital mammography: blinded multi-reader study

Standard Breast Imaging Modalities. Lilian Wang, M.D. Breast Imaging Section Department of Radiology Northwestern Medicine

Since its introduction in 2000, digital mammography has become

National Diagnostic Imaging Symposium 2013 SAM - Breast MRI 1

Look differently. Invenia ABUS. Automated Breast Ultrasound

Breast Tomosynthesis. What is breast tomosynthesis?

Mammography. What is Mammography?

Radiologic and pathologic correlation of non-mass like breast lesions on US and MRI: Benign, high risk, versus malignant

Radiologic and pathologic correlation of non-mass like breast lesions on US and MRI: Benign, high risk, versus malignant

Evaluation of BI-RADS 3 lesions in women with a high risk of hereditary breast cancer.

Mammography. What is Mammography? What are some common uses of the procedure?

Ultrasound Physics & Doppler

Triple-negative breast cancer: which typical features can we identify on conventional and MRI imaging?

Leonard M. Glassman MD Analysis of Breast Calcifications

AMSER Case of the Month: November 2018

ISSN X (Print) Research Article. *Corresponding author Dr. Amlendu Nagar

Armed Forces Institute of Pathology.

Emerging Techniques in Breast Imaging: Contrast-Enhanced Mammography and Fast MRI

The Radiology Aspects

11/10/2015. Prostate cancer in the U.S. Multi-parametric MRI of Prostate Diagnosis and Treatment Planning. NIH estimates for 2015.

RSNA, /radiol Appendix E1. Methods

Melissa Hartman, DO Women s Health Orlando VA Medical Center

Annual Screening Mammography for Breast Cancer in Women 75 Years Old or Older: To Screen or Not to Screen

Diagnostic benefits of ultrasound-guided. CNB) versus mammograph-guided biopsy for suspicious microcalcifications. without definite breast mass

Terminology Tissue Appearance

Real Time Spatial Compound Imaging in breast ultrasound: technology and early clinical experience

Using lesion washout volume fraction as a biomarker to improve suspicious breast lesion characterization

Invasive lobular carcinoma of the breast; spectrum of imaging findings.

BI-RADS Update. Martha B. Mainiero, MD, FACR, FSBI Brown University Rhode Island Hospital

Imaging in breast cancer. Mammography and Ultrasound Donya Farrokh.MD Radiologist Mashhad University of Medical Since

Ultrasonography of the Neck as an Adjunct to FNA. Nicole Massoll M.D.

Malignant Breast Masses Pak Armed Forces Med J 2014; 64 (1): 4-8 ORIGINAL ARTICLES. Sadaf Aziz, Arfan-ul-Haq*, Asad Maqbool Ahmad

CT Laser Mammography CTLM

BI-RADS Categorization As a Predictor of Malignancy 1

Co-PI: Amy Trentham-Dietz, PhD

Photoacoustic Imaging and Therapy in Biomedicine. Nicholas Tobey and Grace Yook. Optical Engineering. Dr. Kasra Daneshvar

Breast Cancer Screening

Validation of the fifth edition BI-RADS ultrasound lexicon with comparison of fourth and fifth edition diagnostic performance using video clips

Principles of Ultrasound. Cara C. Prideaux, M.D. University of Utah PM&R Sports Medicine Fellow March 14, 2012

ACRIN 6666 IM Additional Evaluation: Additional Views/Targeted US

Treatment options for the precancerous Atypical Breast lesions. Prof. YOUNG-JIN SUH The Catholic University of Korea

Indian Journal of Basic and Applied Medical Research; December 2016: Vol.-6, Issue- 1, P

Detailed Program of the second BREAST IMAGING AND INTERVENTIONS PROGRAM am am : Clinician s requirements from breast imaging

Breast Imaging! Ravi Adhikary, MD!

The latest developments - Automated Breast Volume Scanning. Dr. med. M. Golatta

Physical Principles of Ultrasound

The Physics of Ultrasound. The Physics of Ultrasound. Claus G. Roehrborn. Professor and Chairman. Ultrasound Physics

BREAST MRI. VASILIKI FILIPPI RADIOLOGIST CT MRI & PET/CT Departments Hygeia Hospital, Athens, Greece

GE Healthcare. Look differently. Invenia ABUS. Automated Breast Ultrasound

UW Radiology Review Course Breast Calcifications. BI-RADS 5 th Edition

Principal Site Investigator ENHANCE (Evaluation of Thyroid FNA Genomic Signature) study: An IRB approved study with funding to Rochester Regional

Contrast Enhanced Spectral Mammography (CESM) Updates

AMSER Case of the Month: September 2018

Pharmacokinetic evaluation of DCIS

Improving Reading Time of Digital Breast Tomosynthesis with Concurrent Computer Aided Detection

Financial Disclosures

Assessment of extent of disease: digital breast tomosynthesis (DBT) versus full-field digital mammography (FFDM)

Criteria of Malignancy. Evaluation Score

Optical Imaging: Technology and Applications for Radiology

Elastosonography. Prof. Massimo Midiri Direttore Istituto di Radiologia Policlinico Universitario Paolo Giaccone Diagnostica per Immagini, - Palermo

S. Murgo, MD. Chr St-Joseph, Mons Erasme Hospital, Brussels

Screening Mammograms: Questions and Answers

Non-mass Enhancement on Breast MRI. Aditi A. Desai, MD Margaret Ann Mays, MD

Breast Ultrasound: Improving Your Skills & Patient Care

Ultrasound Tomography (UST) a form of ABUS

Breast Cancer Screening and Diagnosis

Hyperechoic breast lesions can be malignant.

Case Report Tubular Carcinoma of the Breast: Advantages and Limitations of Breast Tomosynthesis

Intracystic Papillary Carcinoma of the Breast: Clinical and Radiological Findings with Histopathologic Correlation

Breast Tomosynthesis An additional screening tool in the fight against breast cancer

BCSC Glossary of Terms (Last updated 09/16/2009) DEFINITIONS

Bianca den Dekker, MD - PhD student. Prof dr R.M. Pijnappel Prof dr H.M. Verkooijen Dr M. Broeders

WHAT TO EXPECT. Breast Tomosynthesis An additional screening tool in the fight against breast cancer HOLOGIC. The Women's Health Company

Diagnostic Dilemmas of Breast Imaging

Triple Negative Breast Cancer: Clinical Presentation and Multimodality Imaging Characteristics

Breast Health and Imaging Glossary

Update in Breast Cancer Screening

Use of a Protease Activated System for Real-time Breast Cancer Lumpectomy Margin Assessment

Current Strategies in the Detection of Breast Cancer. Karla Kerlikowske, M.D. Professor of Medicine & Epidemiology and Biostatistics, UCSF

Transcription:

OPTO-ACOUSTIC BREAST IMAGING Imaging-Pathology Correlation of Opto-Acoustic Features in Benign and Malignant Breast Masses Reni Butler, M.D. F. Lee Tucker, M.D. Philip Lavin, Ph.D. Erin Neuschler, M.D.

FINANCIAL DISCLOSURES Dr. Butler s employer, Yale University School of Medicine, had a research grant from Seno Medical Instruments, Inc. Dr. Tucker has a research contract with Seno Medical Instruments, Inc. to provide central pathology review and histopathology analysis services. Dr. Lavin s employer, Boston Biostatistics Research Foundation, has a research contract with Seno Medical Instruments, Inc. to provide study design and analysis services. Dr. Neuschler s employer, Northwestern University Feinberg School of Medicine, had a research grant from Seno Medical Instruments, Inc.

INTRODUCTION Continued advances in technology and adoption of supplemental screening modalities, such as whole-breast US in women with dense breasts, increase sensitivity of screening Specificity of diagnostic work-up using conventional mammography and gray-scale ultrasound remains limited Recent national benchmark study 1 reports PPV of biopsy recommendations at diagnostic mammography (PPV2) of 25.6%, and PPV of performed biopsies (PPV3) of 28.6% PPVs are within recommended range of mammography performance standards BI-RADS 4 category includes broad spectrum of levels of suspicion from as low as >2% for BI-RADS 4A to as high as <95% for BI-RADS 4C 1 Lehman CD, Arao RF, Sprague BL, et al. National Performance Benchmarks for Modern Screening Digital Mammography: Update from the Breast Cancer Surveillance Consortium. Radiology 2016:161174

INTRODUCTION Harms of false positive imaging have been a topic of considerable discussion While the risk/benefit ratio may be debated, it is generally acknowledged that false positive studies are not inconsequential 1-4 Anxiety Discomfort and discouragement from further screening Health care cost Radiation risk OA/US may improve specificity through added functional data 1 Maturitas 2016;92:150-153. 2 Ann Intern Med 2016;164(4):226-235. 3 Acta Radiol 2014;55(10):1174-1179. 4 Breast 2013;22(4):389-394.

WHAT IS OPTO-ACOUSTIC IMAGING? Fused anatomic and functional modality OA/US Gray-scale US shows morphology OA maps show 1. Amount of Hgb in and around breast masses 2. Level of oxygenation (green) vs. deoxygenation (red) of Hgb 3. Morphology of tumor vessels Based on tumor pathophysiology Malignant tumors trigger neoangiogenesis once they reach a size of about 2 mm Malignant tumors are abnormally metabolically active, extracting oxygen from Hgb to a greater degree than most benign masses or normal tissue Grade III Invasive Ductal Carcinoma

BACKGROUND Photoacoustic Imaging Photoacoustic effect described by Bell 1 and Roentgen 2 Brief illumination of tissues causes slight heating and expansion that generates a sound wave OA/US Duplex transducer emits short pulses of laser light at two wavelengths 757 nm absorbed primarily by deoxygenated Hgb 1064 nm absorbed primarily by oxygenated Hgb Momentary heating and expansion of Hgb by bursts of low energy laser light create pressure wave with frequency detected as US signal Received echoes are color coded, reflecting degree of oxygenation/deoxygenation of Hgb Color-coded data is temporally interleaved and co-registered with the gray-scale ultrasound image in real time First ever in a clinical device Currently, the subject of a United States PMA filing with the FDA 1 Am J Sci 1880;(118):305-324 2 Philos Mag 1881;68(5):308-311

Fibroadenoma Grade II IDC

6-on-1 DISPLAY A. Gray-scale US B. Total map total amount of Hgb C. Relative map - relative deoxygenation within and surrounding mass D - E. Long and short wave maps display anatomical features, i.e. architectural distortion similar to mammography F. Combined map - degree of deoxygenation within regions containing the most Hgb

TUMOR ZONES Pathophysiology of benign and malignant tumors defined by 3 zones Tumor interior hypoechoic nidus on gray-scale US Boundary zone hyperechoic halo on gray-scale US Peripheral zone tissue surrounding tumor boundary zone

OA/US FEATURE SCORES Internal Features (3) Vessel Score number and level of deoxygenation of internal vessels Blush Score extent and level of deoxygenation of internal vessels too small to resolve Hemoglobin Score amount of internal Hgb relative to background External Features (2) Boundary Zone Score number and level of deoxygenation, as well as morphology and orientation of BZ vessels Peripheral Zone Score number and orientation of radiating PZ vessels

OA/US FEATURE SCORES Internal Features OA Internal Vascularity and De-oxygenation (Vessel Score) 0 No internal vessels 1 Normal internal vessels without branches, red or green 2 Normal internal vessels with branches, mostly green 3 Internal signal; green = red in amount and less red than background 4 Internal signal; red > green and red > background 5 Multiple internal red vessels OA Internal Tumor Blush and De-oxygenation (Blush Score) 0 No internal vessels 1 Minimal internal signal, all green 2 Mild internal signal; red=green and red + green < background 3 Mild internal signal; red > green and both < background 4 Moderate internal signal; red > green and red also > background 5 Red blush almost fills lesion OA Relative Internal Hemoglobin (Hemoglobin Score) 0 No internal hemoglobin (Hgb) 1 Minimal internal Hgb, less Hgb than background 2 Minimal internal Hgb in discrete vessels, Hgb = background 3 Moderate internal Hgb in discrete vessels, Hgb = background 4 Many large internal vessels containing Hgb amount > background 5 Many large Hgb filled vessels almost fill central nidus of mass External Features y g g OA External Boundary Zone (BZ) Vascularity and De-oxygenation (BZ Score) 0 No capsular/bz vessels 1 Normal capsular/ BZ vessel(s) without branches (long, curved, parallel to capsule, not perpendicular to capsule) 2 Normal capsular/ BZ vessel(s) with normal tapering acutely angled branches, mostly green 3 Capsular/ BZ signal; green = red; red < background red 4 Capsular/ BZ signal; red > green; red > background red 5 >= 3 capsular/ BZ red vessels, some perpendicular 6 Boundary zone de-oxygenated blush OA Peripheral Zone Radiating Vessels Score (Peripheral Zone Score) 0 No peripheral zone peri-tumoral vessels 1 1 or 2 peripheral zone feeding or draining vessels, at least one green, not in a radiating pattern 2 > 2 peripheral zone vessels, but random orientation, not radiating perpendicular to the surface of the mass 3 1 or 2 peripheral zone radiating vessels 4 > 2 peripheral zone radiating vessels on one side of the mass 5 > 2 peripheral zone radiating vessels on more than one side of the mass Note: Higher numbered scores are more suspicious.

PURPOSE To investigate potential of OA/US to enhance distinction between benign and malignant masses by analyzing the strength of its imaging-pathology correlation.

HIPAA-compliant, IRB-approved multi-site study SUBJECTS AND METHODS Pilot study for larger clinical trial of >2,000 subjects at 16 U.S. sites 94 masses in 92 subjects assessed as BI-RADS 3, 4, or 5 on conventional work-up with mammography and gray-scale US were subsequently imaged with OA/US Each mass was scored by blinded independent readers on 3 internal and 2 external OA features Mean OA/US scores were correlated with histology for biopsied benign and malignant masses and for non-biopsied BI-RADS 3 masses considered benign if stable at 12 month follow-up Statistical significance was analyzed using a two-sided Wilcoxon Rank Sum test using a 0.05 significance level

RESULTS 1. Mean OA/US scores for all individual features, as well as summed scores, were higher for malignant masses than for benign masses (p < 0.0001).

CORRELATION OF INTERNAL OA SCORES WITH BENIGN AND MALIGNANT HISTOLOGY

CORRELATION OF EXTERNAL OA SCORES WITH BENIGN AND MALIGNANT HISTOLOGY

RESULTS 2. Less overlap between benign and malignant masses was observed for external OA features than for internal OA features, suggesting that features in the mass boundary zone and periphery may be more consistent in differentiating between benign and malignant masses than those in the tumor interior.

DISTRIBUTION OF INTERNAL AND EXTERNAL SCORES IN BENIGN AND MALIGNANT MASSES

RESULTS 3. Among malignant masses, a trend was observed in the distribution of OA/US features within the 3 tumor zones, with grade I carcinomas yielding low internal and high external scores, while grade III carcinomas produced high internal and low external scores.

MEAN INTERNAL AND EXTERNAL OA SCORES BY HISTOLOGIC GRADE OF INVASIVE MALIGNANCIES

HIGH GRADE (GRADE III) INVASIVE DUCTAL CARCINOMA WITH PAPILLARY FEATURES

LOW GRADE (GRADE I) INVASIVE DUCTAL CARCINOMA

CONCLUSIONS OA/US provides anatomic and functional data without the need for contrast injection or ionizing radiation. In this relatively small population, highly significant differences were observed between benign and malignant masses for all individual internal and external OA scores, summed internal OA scores, summed external OA scores, and total OA scores (all p<0.0001). Non-significant trends were observed in the OA/US features of low versus high-grade invasive carcinomas. Further data based on large, clinical multi-site trial of >2,000 subjects is forthcoming.

Thank you!